PTC THERAPEUTICS, INC. — Net Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/49d6cc59-7421-4bdf-a4a2-6508343e0f6f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $683.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-045528 |
| FY 2024 | $-363.3M | 2024-01-01 – 2024-12-31 | evidence 0001104659-26-045528 |
| FY 2023 | $-626.6M | 2023-01-01 – 2023-12-31 | evidence 0001104659-26-045528 |
| FY 2022 | $-559.0M | 2022-01-01 – 2022-12-31 | evidence 0001104659-26-045528 |
| FY 2021 | $-523.9M | 2021-01-01 – 2021-12-31 | evidence 0001104659-26-045528 |
| FY 2020 | $-438.2M | 2020-01-01 – 2020-12-31 | evidence 0001070081-21-000009 |
| FY 2019 | $-251.6M | 2019-01-01 – 2019-12-31 | evidence 0001070081-20-000064 |
| FY 2018 | $-128.1M | 2018-01-01 – 2018-12-31 | evidence 0001070081-19-000018 |
| FY 2017 | $-79.0M | 2017-01-01 – 2017-12-31 | evidence 0001070081-18-000042 |
| FY 2016 | $-142.1M | 2016-01-01 – 2016-12-31 | evidence 0001070081-17-000062 |
| FY 2015 | $-170.4M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010589 |
| FY 2014 | $-93.8M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-001457 |
| FY 2013 | $-51.6M | 2013-01-01 – 2013-12-31 | evidence 0001047469-15-001457 |
| FY 2012 | $-26.2M | 2012-01-01 – 2012-12-31 | evidence 0001047469-15-001457 |
| FY 2011 | $30.9M | 2011-01-01 – 2011-12-31 | evidence 0001047469-14-001914 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PTC THERAPEUTICS, INC. — all facts · Revenue · Operating Income